my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
31-03-2006: BD Biosciences, a segment of BD, announced a licensing and research agreement with Dynomics BV in the fields of leukemia and lymphoma. Under terms of the agreement, BD has an exclusive worldwide license to specific intellectual property related to the flow cytometry detection of fusion proteins. Financial terms were not disclosed.
Fusion proteins are unique proteins generated by a rearrangement of the chromosomes in a cell. Some disease states such as leukemia are characterized and sub-grouped by chromosomal rearrangements that generate well-recognized changes in cellular composition. Detection and identification of these proteins are important markers for diagnosing and monitoring leukemias. Dynomics focuses on the diagnosis and classification of leukemias and malignant lymphomas.
Watchlist
This is where you can add this news to your personal favourites
BD (Becton, Dickinson and Company) announced the release of a study by researchers from the Johns Hopkins Bloomberg School of Public Health at the XVI International AIDS Conference (AIDS 2006) that demonstrated conducting CD4 tests is a cost-effective laboratory testing strategy for managin ... more
BD Biosciences, a segment of BD, announced a licensing and research agreement with Dynomics BV in the fields of leukemia and lymphoma. Under terms of the agreement, BD has an exclusive worldwide license to specific intellectual property related to the flow cytometry detection of fusion prot ... more
BD Completes Acquisition of GeneOhm Sciences, Inc.
BD (Becton, Dickinson and Company) announced the completion of its acquisition of GeneOhm Sciences, Inc., a pioneer in the development of molecular diagnostic testing for the rapid detection of bacterial organisms, including those known to cause healthcare-associated infections (HAIs), a gr ... more
Personal flow cytometer BD Accuri™ C6 brings cell analysis within reach
The analytical power and versatility of today's laser-based flow cytometry systems have unlocked the mysteries of cell biology and empowered entirely more
BD Cytometric Bead Array: Multiplexed quantitation and detection
BD™ Cytometric Bead Array (CBA) is a flow cytometry application that allows users to quantify multiple proteins simultaneously. The BD CBA system uses more
Heavy and light chain isotypes of mouse IgG1, IgG2a, IgG2b, IgG3, IgA, IgM, and IgE (Anti-Mouse)
BD™ CBA Mouse Immunoglobulin Isotyping Kit more
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. We are focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discove ... more
Right from the start, BD SENSORS has specialized in electronic pressure and level measurement. Apart from an extensive product program BD SENSORS almost offers for each application a suitable solution more
Becton Dickinson de Colombia Ltda.
BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious di ... more
BD Biosciences, a segment of BD, announced a licensing and research agreement with Dynomics BV in the fields of leukemia and lymphoma. Under terms of the agreement, BD has an exclusive worldwide license to specific intellectual property related to the flow cytometry detection of fusion prot ... more
Dynomics aims to be the worldwide leader in the development of tests that provide diagnostic information on the classification of leukemia and lymphoma and information on the prognosis and staging of the disease. The developed tests present the clinician with a meaningful improvement over ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
